Baird Small/Mid Cap Growth Institutional holds a quantitatively derived Negative Morningstar Medalist Rating. The rating indicates the model sees limited potential for the strategy to outperform peers on a risk-adjusted basis over a full market cycle.
Baird Small/Mid Cap Growth Fund Institutional Class BSGIX
- NAV / 1-Day Return 16.92 / 0.00
- Total Assets 73.4M
-
Adj. Expense Ratio
0.850%
- Expense Ratio 0.850%
- Distribution Fee Level Average
- Share Class Type Institutional
- Category Mid-Cap Growth
- Investment Style Small Growth
- Min. Initial Investment 10,000
- Status Open
- TTM Yield 0.00
- Turnover 58%
USD | NAV as of Jul 15, 2026 | 1-Day Return as of Jul 15, 2026, 1:15 AM GMT+0
Morningstar’s Analysis BSGIX
Will BSGIX outperform in the future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 24.3
|
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
|---|---|---|---|
First American Government Obligs U | 4.17 | 3M | Cash and Equivalents |
Curtiss-Wright Corp | 3.36 | 3M | Industrials |
Neurocrine Biosciences Inc | 2.94 | 2M | Healthcare |
The Vita Coco Co Inc | 2.71 | 2M | Consumer Defensive |
Cava Group Inc | 2.47 | 2M | Consumer Cyclical |
UL Solutions Inc Class A common stock | 2.22 | 2M | Industrials |
BWX Technologies Inc | 2.21 | 2M | Industrials |
Comfort Systems USA Inc | 2.19 | 2M | Industrials |
Dutch Bros Inc Class A | 2.17 | 2M | Consumer Cyclical |
Insulet Corp | 2.11 | 2M | Healthcare |